This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Papazian, O. Search for Related Content PubMed PubMed Citation Articles by Papazian, O. Pubmed/NCBI databases Medline Plus Health Information Myasthenia Gravis Social Bookmarking                         What's this?

Topical Review Article: Transient Neonatal Myasthenia Gravis

Department of Neurology, Miami Children's Hospital, Miami, FL

Transient neonatal myasthenia gravis is a postsynaptic neuromuscular transmission defect occurring in 21% of infants born to women with active (and, less commonly, in remission) acquired myasthenia gravis. Although passive-transfer acetylcholine receptor (AChR) antibodies are found in the majority of these newborns, their pathogenic role is questionable because only some infants are symptomatic. Pathogenesis in infants without AChR antibodies is unknown. There is still no biologic marker for prenatal identification of this subpopulation of newborns, although HLA typing may be a promising tool. Sucking, swallowing, and respiratory difficulties are the most common presenting signs in the first day of life. Final diagnosis is done when administration of acetylcholinesterase agents transiently corrects the neuromuscular transmission defect. Serum AChR antibody titers follow the same pattern as their mothers. Supportive management and anticholinesterase agents prior to feedings are necessary in about 80% of patients. In the majority of infants the condition resolves spontaneously. (J Child Neurol 1992;7:135-141).

Journal of Child Neurology, Vol. 7, No. 2, 135-141 (1992)
DOI: 10.1177/088307389200700202


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. F. T. Zenteno Can we consider thymectomy before pregnancy in female patients with myasthenia gravis? Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 411 - 412. [Full Text] [PDF]

				J. M. Hoff, A. K. Daltveit, and N. E. Gilhus Myasthenia gravis: Consequences for pregnancy, delivery, and the newborn Neurology, November 25, 2003; 61(10): 1362 - 1366. [Abstract] [Full Text] [PDF]

				J. M. Hollister, P. Laing, and S. A. Mednick Rhesus Incompatibility as a Risk Factor for Schizophrenia in Male Adults Arch Gen Psychiatry, January 1, 1996; 53(1): 19 - 24. [Abstract] [PDF]